Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Sphingosine 1-phosphate (S1P) is a sphingolipid mediator that is involved in diverse biological functions. Local administration of S1P causes inflammation coupled to a large eosinophil (EO) recruitment in the rat-paw tissue. The inflammatory response is accompanied by an increase in S1P receptors, namely S1P 1 , S1P 2 , S1P 3 , and by an enhanced expression of CCR3, which is the main chemokine receptor known to be involved in EO function. Human EOs constitutively express S1P 1 and, at a lower extent, S1P 2 , S1P 3 receptors. S1P in vitro causes cultured human EO migration and an increase in S1P receptor mRNA copies and strongly up-regulates CCR3 and RANTES (regulated on activation, normal T cell-expressed and secreted) message levels; in particular CCR3 is up-regulated 18,000-fold by S1P. A blocking anti-CCR3 Ab inhibits S1P-induced chemotaxis, implying that S1P acts as specific recruiting signal for EOs not only through its own receptors but also through CCR3. These results show that S1P is involved in EO chemotaxis and contribute to shed light on the complex mechanisms underlying EO recruitment in several diseases such as asthma and some malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Chemokines and leukocyte traffic
Baggiolini, M. (1998) · Nature · doi:10.1038/33340 · Cited by 2,709
Sphingosine-1-phosphate: an enigmatic signalling lipid
Spiegel, S., & Milstien, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1103 · Cited by 2,075
Lee, M.-J., Thangada, S., Claffey, K. P., Ancellin, N., Liu, C. H., Kluk, M., Volpi, M., Sha'afi, R. I., & Hla, T. (1999) · Cell · doi:10.1016/s0092-8674(00)81661-x · Cited by 1,013
A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration
Falk, W., Goodwin, R. H., & Leonard, E. J. (1980) · Journal of Immunological Methods · doi:10.1016/0022-1759(80)90211-2 · Cited by 941
Borish, L. C., & Steinke, J. W. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.108 · Cited by 879
An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils
Hansel, T. T., De Vries, I. J. M., Iff, T., Rihs, S., Wandzilak, M., Betz, S., Blaser, K., & Walker, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90315-7 · Cited by 601
International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature
Chun, J., Goetzl, E. J., Hla, T., Igarashi, Y., Lynch, K. R., Moolenaar, W., Pyne, S., & Tigyi, G. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.265 · Cited by 464
Van Brocklyn, J. R., Lee, M.-J., Menzeleev, R., Olivera, A., Edsall, L., Cuvillier, O., Thomas, D. M., Coopman, P. J. P., Thangada, S., Liu, C. H., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.1.229 · Cited by 460
Role of the Sphingosine-1-Phosphate Receptor EDG-1 in PDGF-Induced Cell Motility
Hobson, J. P., Rosenfeldt, H. M., Barak, L. S., Olivera, A., Poulton, S., Caron, M. G., Milstien, S., & Spiegel, S. (2001) · Science · doi:10.1126/science.1057559 · Cited by 426
Tumor necrosis factor-α induces adhesion molecule expression through the sphingosine kinase pathway
Xia, P., Gamble, J. R., Rye, K.-A., Wang, L., Hii, C. S. T., Cockerill, P., Khew-Goodall, Y., Bert, A. G., Barter, P. J., & Vadas, M. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14196 · Cited by 407
Research works printed but not linked: 2
- Perry, D. K & Kolesnick, R. N. (2003) Cancer Treat. Res. 115, 345–354.12613204
- 10.1016/S0022-1759(80)80014-7 · doi:10.1016/s0022-1759(80)80014-7 · Paper page
Cited by
Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network
Rosen, H., & Goetzl, E. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1650 · Cited by 694
The alliance of sphingosine-1-phosphate and its receptors in immunity
Rivera, J., Proia, R. L., & Olivera, A. (2008) · Nature Reviews Immunology · doi:10.1038/nri2400 · Cited by 616
Brinkmann, V. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.04.006 · Cited by 528
Gergely, P., Nuesslein‐Hildesheim, B., Guerini, D., Brinkmann, V, Traebert, M., Bruns, C., Pan, S., Gray, N., Hinterding, K., Cooke, N., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02061.x · Cited by 305
“, 2008), human eosinophil chemotaxis and selective in vivo recruitment (Roviezzo et al., 2004), as well as mast cell degranulation and chemotaxis (Jolly et al.”
BackgroundSphingosine Kinase: Biochemical and Cellular Regulation and Role in Disease
Taha, T. A., Hannun, Y. A., & Obeid, L. M. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.2.113 · Cited by 276
“It also mobilizes mast cell and monocyte responses acutely (Choi et al., 1996; Melendez et al., 1998; Melendez et al., 1998; Melendez et al., 2002; Jolly et al., 2004) and can induce eosinophil chemotaxis (Roviezzo et al., 2004).”
BackgroundFunctions of the Multifaceted Family of Sphingosine Kinases and Some Close Relatives
Spiegel, S., & Milstien, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600028200 · Cited by 219
Rodrigo, S., Abboud, G., Oh, D., DeMeester, S. R., Hagen, J., Lipham, J., DeMeester, T. R., & Chandrasoma, P. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01594.x · Cited by 195
“It has also been shown that sphingosine-1-phosphate, which is a ubiquitous cell membrane phospholipid that is released during cell damage, is a powerful upregulator of CCR3, which is a CC chemokine receptor that causes release of eotaxin and RANTES (23).”
BackgroundInfluentialSphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation
Snider, A. J., Alexa Orr Gandy, K., & Obeid, L. M. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.008 · Cited by 165
“can influence the migration of inflammatory cells, such as eosinophils [93].”
Blaho, V. A., & Hla, T. (2011) · Chemical Reviews · doi:10.1021/cr200273u · Cited by 147
Sphingolipids and the Balancing of Immune Cell Function: Lessons from the Mast Cell
Olivera, A., & Rivera, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1153 · Cited by 131
Second generation S1P pathway modulators: Research strategies and clinical developments
Bigaud, M., Guerini, D., Billich, A., Bassilana, F., & Brinkmann, V. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.11.001 · Cited by 136
Palma, R. D., Galdo, F. D., Abbate, G., Chiariello, M., Calabrò, R., Forte, L., Cimmino, G., Papa, M. F., Russo, M. G., Ambrosio, G., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.537712 · Cited by 123
Self-citationSchulze, T., Golfier, S., Tabeling, C., Räbel, K., Gräler, M. H., Witzenrath, M., & Lipp, M. (2011) · The FASEB Journal · doi:10.1096/fj.10-179028 · Cited by 115
Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model
Nishiuma, T., Nishimura, Y., Okada, T., Kuramoto, E., Kotani, Y., Jahangeer, S., & Nakamura, S.-I. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00445.2007 · Cited by 108
Sphingosine-1-Phosphate/Sphingosine Kinase Pathway Is Involved in Mouse Airway Hyperresponsiveness
Roviezzo, F., Lorenzo, A. D., Bucci, M., Brancaleone, V., Vellecco, V., Nardo, M. D., Orlotti, D., Palma, R. D., Rossi, F., D’Agostino, B., et al. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0383oc · Cited by 97
“In addition, we have recently showed that S1P acts as a chemotactic agent for human eosinophils in vitro and in vivo ( 19 ).”
BackgroundSelf-citationThe Role of Sphingosine Kinase in a Murine Model of Allergic Asthma
Lai, W.-Q., Goh, H. H., Bao, Z., Wong, W. S. F., Melendez, A. J., & Leung, B. P. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.4323 · Cited by 96
“This suppressive action of DMS on leukocyte migration is consistent with previous studies showing that SphK plays a role in chemotaxis of human peripheral blood neutrophils, macrophages, and eosinophils (12, 13, 27, 35).”
BackgroundResultSphingosine-1-phosphate in allergic responses, asthma and anaphylaxis
Oskeritzian, C. A., Milstien, S., & Spiegel, S. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.05.011 · Cited by 93
“…of S1P by activated mast cells can promote allergic reactions on a broad scale by activating and recruiting many types of immune cells involved in allergic and inflammatory responses, including eosinophils (Roviezzo et al., 2004), Th2 lymphocytes (Sawicka et al., 2003) and neutrophils.”
BackgroundLipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets
Schauberger, E. M., Peinhaupt, M., Cazares, T. A., & Lindsley, A. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0628-3 · Cited by 90
Kume, H., Takeda, N., Oguma, T., Ito, S., Kondo, M., Ito, Y., & Shimokata, K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110718 · Cited by 86
“S1P is released from mast cells and plays an important role not only in regulating mast cell functions but also eosinophil chemotaxis (Rosenfeldt et al., 2003; Roviezzo et al., 2004).”
BackgroundInhibition of eosinophil migration by lactoferrin
Bournazou, I., Mackenzie, K. J., Duffin, R., Rossi, A. G., & Gregory, C. D. (2010) · Immunology & Cell Biology · doi:10.1038/icb.2009.86 · Cited by 84
Sphingosine 1-phosphate regulates cytoskeleton dynamics: Implications in its biological response
Donati, C., & Bruni, P. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.06.015 · Cited by 90
Masini, E., Giannini, L., Nistri, S., Cinci, L., Mastroianni, R., Xu, W., COMHAIR, S. A. A., Li, D., Cuzzocrea, S., Matuschak, G. M., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131565 · Cited by 82
“In this context, S1P levels increase in the airways of asthmatic patients after allergen challenge and correlate with eosinophil number and protein concentration in their bronchoalveolar lavage fluids (Roviezzo et al., 2004).”
BackgroundSu, Z., Zhang, P., Yu, Y., Lu, H., Liu, Y., Ni, P., Su, X., Wang, D., Liu, Y., Wang, J., et al. (2016) · Scientific Reports · doi:10.1038/srep21884 · Cited by 80
RetractedDissecting the Role of the S1P/S1PR Axis in Health and Disease
Aarthi, J. J., Darendeliler, M. A., & Pushparaj, P. N. (2011) · Journal of Dental Research · doi:10.1177/0022034510389178 · Cited by 77
“, 2007), rat paw (Roviezzo et al., 2004),”
Peest, U., Sensken, S., Andréani, P., Hänel, P., Van Veldhoven, P. P., & Gräler, M. H. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21665 · Cited by 72
“Locally S1P is an antiinflammatory mediator that is released during an infection [Cummings et al., 2002; Roviezzo et al., 2004].”
BackgroundSignal Transduction of Sphingosine-1-Phosphate G Protein—Coupled Receptors
Young, N. A., & Brocklyn, J. R. V. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.182 · Cited by 68
“S1P and FTY720 can also affect trafficking of macrophages[181], eosinophils[182], dendritic cells[183,184], and hematopoietic progenitor cells[185].”
BackgroundNovel uses for anti‐platelet agents as anti‐inflammatory drugs
Pitchford, S. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707364 · Cited by 68
“S1P can activate monocytes, endothelial cells, mast cells, eosinophils, smooth muscle cells and promote tissue recruitment of leukocytes (Roviezzo et al., 2004).”
BackgroundLewis, N. D., Haxhinasto, S. A., Anderson, S. M., Stefanopoulos, D. E., Fogal, S. E., Adusumalli, P., Desai, S. N., Patnaude, L. A., Lukas, S. M., Ryan, K. R., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201810 · Cited by 67
“In vitro, mast cells (6), dendritic cells (7), eosinophils (8), NK cells (9), macrophages (10), and monocytes (11) have been shown to migrate toward S1P, albeit weakly.”
BackgroundKurashima, Y., Kunisawa, J., Higuchi, M., Gohda, M., Ishikawa, I., Satoh‐Takayama, N., Shimizu, M., & Kiyono, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1577 · Cited by 64
“administration of S1P induces the infiltration of eosinophils into the peritoneal cavity by enhancing CCR3-RANTES-dependent chemotaxis (29).”
BackgroundOlivera, A., & Rivera, J. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9533-9_8 · Cited by 68
Kim, S., Jung, H., Kim, M., Moon, J., Ban, G., Kim, S. J., Yoo, H., & Park, H. (2020) · Allergy · doi:10.1111/all.14236 · Cited by 59
Kang, Y. P., Lee, W. J., Hong, J. Y., Lee, S. B., Park, J. H., Kim, D., Park, S., Park, C., Park, H., & Kwon, S. W. (2014) · Journal of Proteome Research · doi:10.1021/pr5002059 · Cited by 62
Sphingosine-1-Phosphate Signaling and the Skin
Herzinger, T., Kleuser, B., Schäfer‐Korting, M., & Körting, H. C. (2007) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200708060-00002 · Cited by 60
Li, C., Li, J.-N., Kays, J. S., Guerrero, M. A., & Nicol, G. D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0286-8 · Cited by 54
“hallmark of inflammation [11,12] as well as significant thermal and mechanical hyperalgesia [10,13].”
BackgroundChi, X. X., & Nicol, G. D. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00709.2010 · Cited by 48
“The idea that peripheral S1P can be proinflammatory is supported by the observation that injection of S1P into the paw of a rat produced a dose-dependent edema that was associated with a significant infiltration of eosinophils (Roviezzo et al. 2004).”
Galdo, F. D., & Jiménez, S. A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22877 · Cited by 47
“Migration assays were performed using 6-well Transwell plates with an 8- m–pore-size polycarbonate filter (Costar, Cambridge, MA), as previously described (34).”
MethodLysophospholipids as Mediators of Immunity
Lin, D. A., & Boyce, J. A. (2006) · Advances in immunology · doi:10.1016/s0065-2776(05)89004-2 · Cited by 42
Roviezzo, F., Brancaleone, V., Gruttola, L. D., Vellecco, V., Bucci, M., D’Agostino, B., Cooper, D., Sorrentino, R., Perretti, M., & Cirino, G. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.179168 · Cited by 45
“It is known that the chemotactic action of S1P relies on receptor interaction (Roviezzo et al., 2004; Hashimoto et al., 2008; Ishii et al., 2009; Harvey et al., 2010; Thangada et al., 2010).”
BackgroundSelf-citationChiba, Y., Takeuchi, H., Sakai, H., & Misawa, M. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10202fp · Cited by 40
Kowal, K., Żebrowska, E., & Chabowski, A. (2019) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2019.11.3.330 · Cited by 40
Regulation of CC Ligand 5/RANTES by Acid Sphingomyelinase and Acid Ceramidase
Jenkins, R. W., Clarke, C. J., Canals, D., Snider, A. J., Gault, C. R., Heffernan-Stroud, L. A., Wu, B. X., Simbari, F., Roddy, P. L., Kitatani, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163378 · Cited by 46
Sphingosine‐1‐phosphate/TGF‐β axis drives epithelial mesenchymal transition in asthma‐like disease
Riemma, M. A., Cerqua, I., Romano, B., Irollo, E., Bertolino, A., Camerlingo, R., Granato, E., Rea, G., Scala, S., Terlizzi, M., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15754 · Cited by 40
“Systemic administration of S1P to mice, without any adjuvant addition, induces asthma-like disease characterized by a time and dose-dependent airway hyperresponsiveness and lung inflammation (Roviezzo et al., 2004, 2010, 2015; Sorrentino et al., 2014).”
BackgroundSelf-citationCirillo, P. L., Rosa, S. D., Pacileo, M., Gargiulo, A., Angri, V., Fiorentino, I., Prevete, N., Petrillo, G., Palma, R. D., Leonardi, A., et al. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02923.x · Cited by 39
FTY720 Regulates Bone Marrow Egress of Eosinophils and Modulates Late-Phase Skin Reaction in Mice
Sugita, K., Kabashima, K., Sakabe, J., Yoshiki, R., Tanizaki, H., & TOKURA, Y. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100119 · Cited by 41
Lipid metabolites as regulators of airway smooth muscle function
Clarke, D. L., Dakshinamurti, S., Larsson‐Callerfelt, A., Ward, J., & Yamasaki, A. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.12.003 · Cited by 39
Chemokine Receptors: Attractive Targets for Drug Discovery
Godessart, N. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1361.109 · Cited by 39
Roviezzo, F., Sorrentino, R., Bertolino, A., Gruttola, L. D., Terlizzi, M., Pinto, A., Napolitano, M., Castello, G., D’Agostino, B., Ianaro, A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13033 · Cited by 39
“Airway smooth muscle cells stimulated with S1P release high levels of RANTES and IL-6, which play a critical role in the lung (Ammit et al., 2001; Roviezzo et al., 2004; Jenkins et al., 2011).”
BackgroundSelf-citationSaluja, R., Kumar, A., Jain, M., Goel, S. K., & Jain, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00587 · Cited by 44
“S1P also acts as a chemotactic agent for eosinophils through RANTES and CCR3, further implying an involvement of S1P in the pathophysiology of asthma (41).”
BackgroundSu, Z., Yin, J., Wang, T., Sun, Y., Ni, P., Ma, R., Zhu, H., Zheng, D., Shen, H., Xu, W., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12324 · Cited by 33
D’Agostino, B., Roviezzo, F., Palma, R. D., Terracciano, S., Nardo, M. D., Gallelli, L., F., A. G., D’Aiuto, E., Russo, M., Cirino, G., et al. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02793.x · Cited by 34
Self-citationCools‐Lartigue, J., Chang, S.-Y., McKendy, K. M., Mayrand, S., Marcus, V., Fried, G. M., & Ferri, L. E. (2012) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2012.01385.x · Cited by 32
Kays, J. S., Li, C., & Nicol, G. D. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00053.2012 · Cited by 32
“, edema) (44, 45), as well as significant thermal and mechanical hyperalgesia (12, 28).”
BackgroundEosinophil recruitment to nasal nerves after allergen challenge in allergic rhinitis
Thornton, M. A., Akasheh, N., Walsh, M., Moloney, M. A., Sheahan, P. O., Smyth, C. M., Walsh, R. M., Morgan, R. K., Curran, D. R., Walsh, M. T., et al. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.02.008 · Cited by 31
“We and others have shown that eosinophils express receptors for the bioactive lipids S1P and LPA [4,25–27].”
Unraveling the complexities of sphingosine-1-phosphate function: The mast cell model
Olivera, A. (2008) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2008.02.005 · Cited by 33
“The consequent production of local S1P gradients by stimulated mast cells in the skin, gut and other tissues where mast cells reside may not only recruit a number of immune cells [22,23,25,26,35,92,93], but also influence the type of the immune response.”
BackgroundChe, W., Parmentier, J., Seidel, P., Manetsch, M., Ramsay, E. E., Alkhouri, H., Ge, Q., Armour, C. L., & Ammit, A. J. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0208oc · Cited by 28
Sphingosine‐1‐phosphate activates mouse vagal airway afferent C‐fibres via S1PR3 receptors
Patil, M. J., Meeker, S., Bautista, D. M., Dong, X., & Undem, B. J. (2019) · The Journal of Physiology · doi:10.1113/jp277521 · Cited by 29
“In keeping with this, treating mice with S1P or FTY720 mimics respiratory allergen challenge, in that it leads to airways hyperreactivity (Roviezzo et al. 2004, 2010; Trifilieff & Fozard, 2012; Trankner et al. 2014).”
BackgroundSphingosine-1-phosphate synthesis and functions in mast cells
Price, M. M., Oskeritzian, C. A., Milstien, S., & Spiegel, S. (2008) · Future Lipidology · doi:10.2217/17460875.3.6.665 · Cited by 27
Sphingosine Kinases promote IL-17 expression in human T lymphocytes
Barra, G., Lepore, A., Gagliardi, M., Somma, D., Matarazzo, M. R., Costabile, F., Pasquale, G., Mazzoni, A., Gallo, C., Nuzzo, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31666-1 · Cited by 29
Chiba, Y., Suzuki, K., Uechi, M., Kurihara, E., Goto, K., Sakai, H., & Misawa, M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.05.005 · Cited by 27
Price, M. M., Kapitonov, D., Allegood, J. C., Milstien, S., Oskeritzian, C. A., & Spiegel, S. (2009) · The FASEB Journal · doi:10.1096/fj.08-128900 · Cited by 25
“S1P also increased expression of MCP-1, MIP-1 , MIP-1 , and MIP-2 in MCs, all important modulators of monocyte, macrophage, and eosinophil recruitment and inflammation (18, 19, 35).”
BackgroundSphingosine-1-Phosphate Aggravates Antigen-Induced Airway Inflammation in Mice
Chiba, Y., Suzuki, K., Kurihara, E., Uechi, M., Sakai, H., & Misawa, M. (2010) · The Open Respiratory Medicine Journal · doi:10.2174/1874306401004010082 · Cited by 23
“Results: The airway inflammation induced by antigen exposure was significantly augmented by the intranasal administration of S1P: the cell number in BALFs of the S1P-treated, antigen-challenged mice (S1P-Challenged, 48.9±4.8 x 10 4 /mL BALF) was significantly increased as compared with those of the…”
ResultInfluentialPerspectives on immunomodulation early in life
Diesner, S. C., Förster‐Waldl, E., Olivera, A., Pollak, A. J., Jensen‐Jarolim, E., & Untersmayr, E. (2012) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2011.01259.x · Cited by 26
Marsolais, D., Yagi, S., Kago, T., Leaf, N. B., & Rosen, H. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066811 · Cited by 24
“In contrast, administration of exogenous S1P exacerbates bronchial hyper-responsiveness (Roviezzo et al., 2004) by favoring mast cell and eosinophil accumulation in the lung, whereas reduction of S1P levels using sphingosine kinases inhibitors leads to alleviation of AAI (Nishiuma et al.”
BackgroundB Cell Depletion Increases Sphingosine-1-Phosphate–Dependent Airway Inflammation in Mice
Sorrentino, R., Bertolino, A., Terlizzi, M., Iacono, V. M., Maiolino, P., Cirino, G., Roviezzo, F., & Pinto, A. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0207oc · Cited by 22
Self-citationSingh, D., Bassi, M., Balzano, D., Lucci, G., Emirova, A., Anna Nandeuil, M., Jellema, G., Afolabi, E. K., Leaker, B., Kornmann, O., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16146 · Cited by 20
Roviezzo, F., Sorrentino, R., Terlizzi, M., Riemma, M. A., Iacono, V. M., Rossi, A., Spaziano, G., Pinto, A., D’Agostino, B., & Cirino, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01336 · Cited by 20
Self-citationCunto, G. D., Brancaleone, V., Riemma, M. A., Cerqua, I., Vellecco, V., Spaziano, G., Cavarra, E., Bartalesi, B., D’Agostino, B., Lungarella, G., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14861 · Cited by 23
“K/S1P pathway in the control of airway function and pulmonary inflammation has been demonstrated (Price et al., 2013; Roviezzo et al., 2004; Roviezzo et al., 2007; Roviezzo et al., 2010; Roviezzo et al., 2015; Roviezzo et al., 2016).”
BackgroundSelf-citationA common cortactin gene variation confers differential susceptibility to severe asthma
Ma, S., Flores, C., Wade, M. S., Dudek, S. M., Nicolae, D. L., Ober, C., & Garcia, J. G. N. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20343 · Cited by 21
“…asthmatic (but not control) subjects after segmental antigen challenge [Ammit et al., 2001], in mediating lymphocyte chemotaxis and transmigration [Roviezzo et al., 2004; Brinkmann and Baumruker, 2006], and for the enhancement of endothelial and vascular smooth muscle cell proliferation and…”
BackgroundELOVL6 deficiency aggravates allergic airway inflammation through the ceramide-S1P pathway in mice
Yoshida, K., Morishima, Y., Ano, S., Sakurai, H., Kuramoto, K., Tsunoda, Y., Yazaki, K., Nakajima, M., SHERPA, M. T., Matsuyama, M., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.12.808 · Cited by 19
Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism
Vogt, D., & Stark, H. (2016) · Medicinal Research Reviews · doi:10.1002/med.21402 · Cited by 21
The role of sphingosine 1-phosphate in immunity and sepsis.
Gräler, M. H. (2012) · Europe PMC (PubMed Central) · Cited by 25
Leukocyte navigation mechanisms as targets in airway diseases
Medina‐Tato, D. A., Watson, M., & Ward, S. G. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.008 · Cited by 17
Sashio, T., Kume, H., Takeda, N., Asano, T., 辻, 清., Kondo, M., Hasegawa, Y., & Shimokata, K. (2012) · Allergology International · doi:10.2332/allergolint.10-oa-0299 · Cited by 13
Involvement of Lysophospholipids in Pulmonary Vascular Functions and Diseases
Kume, H., Harigane, R., & Rikimaru, M. (2024) · Biomedicines · doi:10.3390/biomedicines12010124 · Cited by 14
“S1P acts on eosinophils to facilitate chemotaxis and recruitment through its receptors and CCR3 [136] and S1P also acts on endothelial cells to enhance the expression of adhesion molecules, resulting in recruitment to the lungs via the adhesion of eosinophils to endothelial cells [13] (Figure 5).”
BackgroundTargeting S1PR1 May Result in Enhanced Migration of Cancer Cells in Bladder Carcinoma
Chen, C.-L., Meng, E., Wu, S., Lai, H.-F., YiShan, L., Yang, M.-H., Tsao, C., Kao, C., & Chiu, Y. (2021) · Cancers · doi:10.3390/cancers13174474 · Cited by 11
Proton pump inhibitor responsive esophageal eosinophilia, a distinct disease entity?
Munday, W. R., & Zhang, X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10419 · Cited by 12
Role of adiponectin in sphingosine-1-phosphate induced airway hyperresponsiveness and inflammation
Nigro, E., Matteis, M., Roviezzo, F., Iacono, V. M., Scudiero, O., Spaziano, G., Tartaglione, G., Urbanek, K., Filosa, R., Daniele, A., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.004 · Cited by 11
Self-citationCostello, R. W., Maloney, M., Atiyeh, M., Gleich, G. J., & Walsh, M. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12053237 · Cited by 10
“S1P promotes airway remodeling [24] and we and others have shown that eosinophils express functional S1P receptors [27,28].”
FERREIRA-DUARTE, A. P., Pinheiro‐Torres, A. S., Anhê, G. F., Condino‐Neto, A., Antunes, E., & DeSouza, I. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00518 · Cited by 12
“For the eosinophil chemotaxis assays, a 96-multiwell chemotaxis chamber was used (Roviezzo et al., 2004).”
MethodSelf-citationPossible Involvement of Lysophospholipids in Severe Asthma as Novel Lipid Mediators
Kume, H., Kazama, K., Sato, R., & Sato, Y. (2025) · Biomolecules · doi:10.3390/biom15020182 · Cited by 11
“S1P has the ability to facilitate chemotaxis and the recruitment of eosinophils to the lungs through its receptors and CC chemokine receptor 3 (CCR3) [15,158]; moreover, exter-nal S1P also enhances the expression of VCAM-1 and ICAM-1 in the endothelium [15,159] (Table 4).”
Gray, N., Limberg, M. M., Wiebe, D., Weihrauch, T., Langner, A., Brandt, N., Bräuer, A. U., & Raap, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416117 · Cited by 6
“Together these findings for basophils indicate that biological effects of S1P binding to the S1PRs do not manifest in a short time frame, and longer stimulation times might be needed to investigate and determine S1P-induced effects.”
BackgroundInfluentialEosinophils as drivers of bacterial immunomodulation and persistence
Parrish, K. M., & Gestal, M. C. (2024) · Infection and Immunity · doi:10.1128/iai.00175-24 · Cited by 6
Makled, M. N., & El‐Sheakh, A. R. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23266 · Cited by 5
Chiba, Y., Takeuchi, H., Sakai, H., & Misawa, M. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70521-7 · Cited by 5
“The finding that S1P can act as a chemotactic agent for eosinophils further suggests the involvement of S1P in the pathophysiology of asthma [18].”
BackgroundVellecco, V., Esposito, E., Indolfi, C., Saviano, A., Panza, E., Bucci, M., Brancaleone, V., Cirino, G., Bianca, R. D. D. V., Sorrentino, R., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115536 · Cited by 3
Self-citationKowal, K., Żebrowska, E., & Chabowski, A. (2019) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2019.11.e30 · Cited by 3
Antiarthrotic and Immunomodulatory Activity
Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_10 · Cited by 2
Sequence analysis of the S1PR1 gene in river buffalo
Stafuzza, N. B., Naressi, B. C. M., Borges, M. M., & Amaral, M. E. J. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15016363 · Cited by 2
“S1PR1 is expressed by the majority of innate and adaptive immune cells such as macrophages, eosinophils, dendritic cells, mast cells, natural killer cells, T cells, B cells, and natural killer T cells (Dorsam et al., 2003; Jolly et al., 2004; Roviezzo et al., 2004; Czeloth et al., 2007; Allende et al., 2007; Hughes et…”
BackgroundWalsh, M. T., & Costello, R. W. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02674.x · Cited by 1
Sphingosine-1-Phosphate and the Regulation of Immune Cell Trafficking
Allende, M. L., & Proia, R. L. (2006) · Springer eBooks · doi:10.1007/4-431-34200-1_30 · Cited by 1
Methods for Testing Immunological Factors
Braddock, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_45 · Cited by 1
Tabeling, C. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7458
Mathematisch-naturwissenschaftlichen Fakultät, I. (2007)
Chiba, Y., Suzuki, K., Sakai, H., & Misawa, M. (2010) · The Open Inflammation Journal
Yang, Y., & Uhlig, S. (2011) · RWTH Publications (RWTH Aachen)
Review Article The role of sphingosine 1-phosphate in immunity and sepsis
Gräler, M. H. (2012)
Methods for Testing Immunological Factors
Braddock, M. (2024) · Springer eBooks · doi:10.1007/978-3-030-73317-9_149-1
Methods for Testing Immunological Factors
Braddock, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_149
Methods for Testing Immunological Factors
Braddock, M. (2015) · Springer eBooks · doi:10.1007/978-3-642-27728-3_45-1
Metadata
- Authors
- Roviezzo, F., Del Galdo, F., Abbate, G., Bucci, M., D'Agostino, B., Antunes, E., De Dominicis, G., Parente, L., Rossi, F., Cirino, G., & De Palma, R.
- Affiliations
- University of Salerno (IT)
- Dipartimento di Scienze Farmaceutiche, Università di Salerno, 84084 Salerno, Italy; Dipartimento di Internistica Clinica e Sperimentale, Seconda Università di Napoli, 80131 Naples, Italy; Dipartimento di Farmacologia Sperimentale, Università di Napoli Federico II, 80131 Naples, Italy; Dipartimento di Medicina Sperimentale, Sezione di Farmacologia L. Donatelli, Seconda Università degli Studi di Napoli, 80138 Naples, Italy; Department of Pharmacology, Universidade Estadual de Campinas, Campinas, CEP...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-07-14
- Volume
- 101
- Issue
- 30
- Pages
- 11170-11175
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC503758
- OpenAlex
- W2012591726
- Semantic Scholar
- 3d8e4ddcff8a291978b4c0668675a1f34f587418
- Cited by
- 100
- References
- 36
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 5 · 2013: 5 · 2012: 8
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- sphingosine-1-phosphate, eosinophils, eosinophil chemotaxis, eosinophil recruitment, S1P receptors, CCR3, RANTES, inflammation, eosinophil migration, asthma
- MeSH terms
- Animals, Chemotaxis, Leukocyte, Edema, Eosinophils, Flow Cytometry, Gene Expression Regulation, Humans, Lysophospholipids, Sphingosine, Chemokine CCL5, Receptors, Chemokine, Rats, Receptors, CCR3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.